Treatment with reduced dose trimethoprim-sulfamethoxazole is effective in mild to moderate Pneumocystis jirovecii pneumonia in patients with hematologic malignancies.
Helena HammarströmAnders KriforsSimon AthlinVanda FrimanKaran GolestaniAnita HällgrenGisela OttoSara OwelingKarlis PauksensAmelie KinchOla BlennowPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
In this cohort of 113 patients with hematologic malignancies, reduced dose TMP-SMX was effective and safe for treating mild to moderate PJP.